3.6815
price down icon4.19%   -0.1385
 
loading
Personalis Inc stock is traded at $3.6815, with a volume of 10,156. It is down -4.19% in the last 24 hours and down -28.46% over the past month. Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
See More
Previous Close:
$3.82
Open:
$3.66
24h Volume:
10,156
Relative Volume:
0.01
Market Cap:
$315.10M
Revenue:
$73.48M
Net Income/Loss:
$-108.30M
P/E Ratio:
-1.6362
EPS:
-2.25
Net Cash Flow:
$-67.17M
1W Performance:
-15.40%
1M Performance:
-28.46%
6M Performance:
-37.26%
1Y Performance:
+111.24%
1-Day Range:
Value
$3.66
$3.66
1-Week Range:
Value
$3.38
$4.4259
52-Week Range:
Value
$1.135
$7.20

Personalis Inc Stock (PSNL) Company Profile

Name
Name
Personalis Inc
Name
Phone
650-752-1300
Name
Address
6600 DUMBARTON CIRCLE, FREMONT, CA
Name
Employee
229
Name
Twitter
@PersonalisInc
Name
Next Earnings Date
2024-11-06
Name
Latest SEC Filings
Name
PSNL's Discussions on Twitter

Compare PSNL with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
PSNL
Personalis Inc
3.66 315.10M 73.48M -108.30M -67.17M -2.25
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
510.25 191.99B 42.88B 6.34B 7.27B 16.53
Diagnostics & Research icon
DHR
Danaher Corp
205.63 145.87B 23.88B 3.90B 5.30B 5.28
Diagnostics & Research icon
A
Agilent Technologies Inc
118.78 33.47B 6.53B 1.26B 1.31B 4.35
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
412.88 33.04B 3.90B 887.87M 798.08M 10.67
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
183.09 31.99B 15.41B 1.37B 2.11B 7.50

Personalis Inc Stock (PSNL) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-06-23 Upgrade Needham Hold → Buy
Jan-07-22 Upgrade BofA Securities Neutral → Buy
Nov-05-21 Downgrade Morgan Stanley Overweight → Equal-Weight
Nov-03-21 Downgrade Needham Buy → Hold
Oct-15-21 Resumed Cowen Outperform
Sep-20-21 Reiterated Needham Buy
May-06-21 Upgrade Oppenheimer Perform → Outperform
Jan-28-21 Initiated Truist Buy
Jan-04-21 Downgrade BofA Securities Buy → Neutral
Nov-12-20 Reiterated Needham Buy
Nov-06-20 Downgrade Oppenheimer Outperform → Perform
Oct-19-20 Initiated Citigroup Buy
Oct-08-20 Initiated BTIG Research Buy
Aug-27-20 Initiated H.C. Wainwright Buy
Aug-18-20 Initiated Needham Buy
Sep-26-19 Upgrade BofA/Merrill Neutral → Buy
Jul-15-19 Initiated BofA/Merrill Neutral
Jul-15-19 Initiated Cowen Outperform
Jul-15-19 Initiated Morgan Stanley Overweight
Jul-15-19 Initiated Oppenheimer Outperform
View All

Personalis Inc Stock (PSNL) Latest News

pulisher
Mar 12, 2025

Hold Rating for Personalis: Balancing Strong Enterprise Sales and Future Uncertainties - TipRanks

Mar 12, 2025
pulisher
Mar 08, 2025

Cathie Wood-Led Ark Invest Roblox, Roku, UiPath As Markets Take A Dip - Benzinga

Mar 08, 2025
pulisher
Mar 07, 2025

Personalis Stock Price, Quotes and Forecasts | NASDAQ:PSNL - Benzinga

Mar 07, 2025
pulisher
Mar 03, 2025

Personalis stock target cut to $7 by BTIG, maintains Buy rating - Investing.com Canada

Mar 03, 2025
pulisher
Mar 03, 2025

New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection - Yahoo Finance

Mar 03, 2025
pulisher
Mar 03, 2025

Personalis’ (PSNL) “Buy” Rating Reiterated at HC Wainwright - Defense World

Mar 03, 2025
pulisher
Mar 03, 2025

Needham & Company LLC Cuts Personalis (NASDAQ:PSNL) Price Target to $7.00 - Defense World

Mar 03, 2025
pulisher
Mar 02, 2025

Personalis, Inc. (NASDAQ:PSNL) Just Reported Earnings, And Analysts Cut Their Target Price - Simply Wall St

Mar 02, 2025
pulisher
Mar 01, 2025

Personalis (NASDAQ:PSNL) Price Target Lowered to $7.00 at Needham & Company LLC - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

Personalis Full Year 2024 Earnings: Beats Expectations - Yahoo Finance

Mar 01, 2025
pulisher
Feb 28, 2025

Personalis (NASDAQ:PSNL) Announces Quarterly Earnings Results - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Personalis stock target cut to $7.00 at Needham, retains buy rating By Investing.com - Investing.com South Africa

Feb 28, 2025
pulisher
Feb 28, 2025

Personalis (NASDAQ:PSNL) Announces Earnings Results, Beats Expectations By $0.09 EPS - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Personalis files to sell 14.04M shares of common stock for holders - MSN

Feb 28, 2025
pulisher
Feb 28, 2025

Personalis stock target cut to $7.00 at Needham, retains buy rating - Investing.com Canada

Feb 28, 2025
pulisher
Feb 28, 2025

Personalis, Inc. (NASDAQ:PSNL) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 28, 2025
pulisher
Feb 28, 2025

A Glimpse Into The Expert Outlook On Personalis Through 7 Analysts - Benzinga

Feb 28, 2025
pulisher
Feb 28, 2025

Personalis Inc (PSNL) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada

Feb 28, 2025
pulisher
Feb 28, 2025

ARK Investment Management LLC Sells 310,088 Shares of Personalis, Inc. (NASDAQ:PSNL) - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Personalis Inc (PSNL) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic ... - Yahoo Finance

Feb 28, 2025
pulisher
Feb 28, 2025

Personalis: Q4 Earnings Snapshot - Thehour.com

Feb 28, 2025
pulisher
Feb 28, 2025

Personalis’ Earnings Call: Growth Amid Challenges - TipRanks

Feb 28, 2025
pulisher
Feb 27, 2025

Personalis Reports Fourth Quarter and Full Year 2024 Financial Results - BioSpace

Feb 27, 2025
pulisher
Feb 27, 2025

Personalis Reports 2024 Growth and Strategic Partnerships - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Personalis (PSNL) Reports Q4 Loss, Tops Revenue Estimates - MSN

Feb 27, 2025
pulisher
Feb 27, 2025

Earnings call transcript: Personalis Q4 2024 beats EPS forecast, stock dips - Investing.com India

Feb 27, 2025
pulisher
Feb 27, 2025

Personalis: Q4 Earnings Snapshot -February 27, 2025 at 04:23 pm EST - Marketscreener.com

Feb 27, 2025
pulisher
Feb 27, 2025

Personalis price target lowered to $8 from $11 at H.C. Wainwright - MSN

Feb 27, 2025
pulisher
Feb 27, 2025

Personalis Inc to Host Earnings Call - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 26, 2025

Personalis Inc (PSNL) Q4 2024 Earnings Report Preview: What To L - GuruFocus.com

Feb 26, 2025
pulisher
Feb 26, 2025

Personalis Inc (PSNL) Q4 2024 Earnings Report Preview: What To Look For - Yahoo Finance

Feb 26, 2025
pulisher
Feb 25, 2025

Personalis Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView

Feb 25, 2025
pulisher
Feb 24, 2025

Personalis (PSNL) Reports Q2 Loss, Tops Revenue Estimates - MSN

Feb 24, 2025
pulisher
Feb 24, 2025

Personalis Inc (NASDAQ: PSNL) Stock Sentiment: What’s Wall Street Saying? - Stocks Register

Feb 24, 2025
pulisher
Feb 22, 2025

Personalis (PSNL) to Release Earnings on Thursday - MarketBeat

Feb 22, 2025
pulisher
Feb 20, 2025

Personalis (PSNL) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance

Feb 20, 2025
pulisher
Feb 19, 2025

Personalis Inc (PSNL) Stock: Exploring a Year of Highs, Lows, and Trading Volume - The InvestChronicle

Feb 19, 2025
pulisher
Feb 19, 2025

Personalis (PSNL) Projected to Post Earnings on Wednesday - Defense World

Feb 19, 2025
pulisher
Feb 18, 2025

Personalis to Participate at the TD Cowen's 45th Annual Health Care Conference - Business Wire

Feb 18, 2025
pulisher
Feb 14, 2025

PSNLPersonalis Latest Stock News & Market Updates - StockTitan

Feb 14, 2025
pulisher
Feb 14, 2025

297,889 Shares in Personalis, Inc. (NASDAQ:PSNL) Bought by abrdn plc - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

Exciting Technology At Personalis, But Profitability Eludes Them (NASDAQ:PSNL) - Seeking Alpha

Feb 14, 2025
pulisher
Feb 14, 2025

SG Americas Securities LLC Buys New Position in Personalis, Inc. (NASDAQ:PSNL) - Defense World

Feb 14, 2025
pulisher
Feb 14, 2025

Sumitomo Mitsui Trust Group Inc. Sells 59,295 Shares of Personalis, Inc. (NASDAQ:PSNL) - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

Personalis to Announce Fourth Quarter and Full Year 2024 Financial Results - BioSpace

Feb 14, 2025
pulisher
Feb 13, 2025

Cancer Genomics Pioneer Personalis Unveils Q4 Earnings DateKey Details Inside - StockTitan

Feb 13, 2025
pulisher
Feb 10, 2025

Understanding the Risks of Investing in Personalis Inc (PSNL) - Knox Daily

Feb 10, 2025
pulisher
Feb 06, 2025

Wall Street analysts’ outlook for Personalis Inc (PSNL) - SETE News

Feb 06, 2025
pulisher
Feb 06, 2025

Should You Expect A Quick Recovery From Personalis Inc (NASDAQ: PSNL) After -35.08% Decline From High? - Marketing Sentinel

Feb 06, 2025
pulisher
Feb 06, 2025

BlackRock, Inc.'s Strategic Acquisition of Personalis Inc. Shares - GuruFocus.com

Feb 06, 2025
pulisher
Feb 05, 2025

Personalis Inc (PSNL) is a good investment, but the stock may be overvalued - US Post News

Feb 05, 2025

Personalis Inc Stock (PSNL) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Personalis Inc Stock (PSNL) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Chen Richard
CHIEF MEDICAL OFFICER AND EVP
Jan 28 '25
Sale
5.79
519
3,005
123,367
Chen Richard
CHIEF MEDICAL OFFICER AND EVP
Dec 16 '24
Sale
3.82
4,834
18,466
123,886
Moore Stephen Michael
SVP and Chief Legal Officer
Dec 16 '24
Sale
3.82
1,513
5,780
65,875
Tachibana Aaron
CFO AND COO
Dec 16 '24
Sale
3.82
6,865
26,224
167,098
Tachibana Aaron
CFO AND COO
Nov 18 '24
Sale
3.79
1,307
4,954
173,963
Moore Stephen Michael
SVP and Chief Legal Officer
Nov 18 '24
Sale
3.79
1,693
6,416
67,388
Chen Richard
CHIEF MEDICAL OFFICER AND EVP
Nov 18 '24
Sale
3.79
921
3,491
128,720
Hall Christopher M
PRESIDENT AND CEO
Nov 01 '24
Sale
5.38
26,443
142,263
178,098
Tempus AI, Inc.
10% Owner
Aug 16 '24
Buy
5.07
3,500,000
17,745,000
12,718,800
Chen Richard
CHIEF MEDICAL OFFICER AND EVP
Jul 30 '24
Sale
2.97
524
1,556
127,227
$143.83
price up icon 0.34%
diagnostics_research DGX
$168.82
price up icon 1.44%
diagnostics_research LH
$235.65
price down icon 0.50%
diagnostics_research WAT
$366.12
price down icon 1.79%
diagnostics_research MTD
$1,209.57
price up icon 0.66%
diagnostics_research IQV
$183.09
price up icon 0.92%
Cap:     |  Volume (24h):